海正药业(600267.SH)再次提交上海松江区部分房产的挂牌申请
格隆汇8月20日丨海正药业(600267.SH)公布,截至2019年8月13日、8月14日,公司公开挂牌转让的上述房产延长挂牌期期满,公司未征集到符合条件的意向受让方。公司于8月19日再次向上海联交所提交了上海市松江区小昆山镇广富林路4855弄16号、17号厂房和北京市宣武区南滨河路23号3号楼1901室、1902室房产的挂牌申请,挂牌自2019年8月21日至2019年9月18日止,若挂牌期满后,未征集到满足摘牌条件的意向受让方,则不变更挂牌条件,按照5个工作日为一个周期延长,最多延长6个周期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.